SCHEMBL3523310

SCHEMBL3523310

Brc1cc(Br)cc(-c2ccccc2-c2ccccc2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.54
MAPK1 P28482 2/20 0.54
AKR1C3 P42330 1/20 0.46
AKR1C2 P52895 1/20 0.46
AKR1C1 Q04828 1/20 0.46
BACE1 P56817 1/20 0.44
HSD17B10 Q99714 2/20 0.42
HPGD P15428 1/20 0.42
BCL2L1 Q07817 1/20 0.42
CYP2A6 P11509 1/20 0.42
ABL1 P00519 1/20 0.41
ABCB1 P08183 1/20 0.41
BCR P11274 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PTGS2 P35354 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13642473 0.85 ALDH1A1 (0.48) ALDH1A1MAPK1AKR1C3AKR1C2AKR1C1
SCHEMBL24200897 0.84 ALDH1A1 (0.48) ALDH1A1MAPK1AKR1C3AKR1C2AKR1C1
SCHEMBL2278862 0.83 ALDH1A1 (0.52) ALDH1A1MAPK1BACE1HSD17B10HPGD
SCHEMBL24716100 0.82 ALDH1A1 (0.41) ALDH1A1MAPK1AKR1C3AKR1C2AKR1C1
SCHEMBL29092148 0.82 MAOA (0.45) ALDH1A1MAPK1AKR1C3AKR1C2AKR1C1
SCHEMBL1562747 0.81 ALDH1A1 (0.60) ALDH1A1MAPK1AKR1C3AKR1C2AKR1C1
SCHEMBL4142770 0.81 ALDH1A1 (0.50) ALDH1A1MAPK1BACE1HSD17B10HPGD
SCHEMBL28199592 0.81 ALDH1A1 (0.58) ALDH1A1MAPK1AKR1C3AKR1C2AKR1C1
SCHEMBL12996631 0.79 ALDH1A1 (0.57) ALDH1A1MAPK1AKR1C3AKR1C2AKR1C1
SCHEMBL29410298 0.79 ALDH1A1 (0.74) ALDH1A1MAPK1BACE1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109415354-A Charge transport material, compound, delayed fluorescence material, and organic light-emitting element 九州有机光材股份有限公司 2019-03-01 CN disclosed
US-7858794-B2 Tetrahydroquinoline derivatives N.V. ORGANON (NL) 2010-12-28 US disclosed
US-20070116982-A1 Host material for organic electroluminescent element and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2007-05-24 US disclosed
EP-1708547-A1 HOST MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2006-10-04 EP disclosed
US-20060142334-A1 Tetrahydroquinoline derivatives MERCK SHARP & DOHME B.V. (NL) 2006-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060142334-A1 Tetrahydroquinoline derivatives GNRHR, KCNH3, HCAR3 ALDH1A1 1133/4885MAPK1 3862/4885AKR1C3 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.